Ascendis Pharma A/S ADR (NASDAQ:ASND) Stock Reported EPS of -$0.05 in Last Quarter
Jefferies raised the price target for the Ascendis Pharma A/S ADR (NASDAQ:ASND) stock to “a Buy”. The rating was released on December 20, 2023, according to finviz. The stock was downgraded by Morgan Stanley, who disclosed in a research note on April 04, 2023, from Overweight to Equal-Weight and set the price objective to $108. […]
Ascendis Pharma A/S ADR (ASND) Stock is Just Right Size-Neither Too Big Nor Too Small
Jefferies raised the price target for the Ascendis Pharma A/S ADR (NASDAQ:ASND) stock to “a Buy”. The rating was released on December 20, 2023, according to finviz. The stock was downgraded by Morgan Stanley, who disclosed in a research note on April 04, 2023, from Overweight to Equal-Weight and set the price objective to $108. […]
